Find uplifting stories about heroes, innovations, and solutions
4844 results for "crohn's disease"
University of Edinburgh researchers discovered how immune cells trigger debilitating scar tissue in Crohn's disease patients, opening the door for treatments that could prevent the condition's most challenging complication. The breakthrough could help millions avoid surgery and transform lives.
Researchers have discovered what causes devastating scar tissue in Crohn's disease patients, opening the door to treatments that could prevent scarring rather than just treating inflammation. For the first time, scientists can target the root cause of fibrosis that sends thousands to surgery each year.
Scientists at Mayo Clinic discovered why some inflammatory bowel disease patients don't respond to standard treatments, opening the door to new therapies. The breakthrough centers on a molecule that acts like a dimmer switch for gut inflammation.
Researchers have developed a potential new treatment for Crohn's disease by mimicking a rare gene variant that naturally protects some people from inflammatory bowel disease. The breakthrough demonstrates a complete path from genetic discovery to actual medicine, offering hope for 3 million Americans living with IBD.
A simple injection during surgery is helping Crohn's disease patients heal faster and better than ever before. The treatment costs just 1% of existing alternatives while nearly doubling cure rates.
A groundbreaking clinical trial found that people with Crohn's disease who ate all their meals within an 8-hour window saw dramatic improvements in symptoms and inflammation. The best part? They didn't have to change what they ate or count calories.
Patients with hard-to-treat inflammatory bowel disease saw remarkable results when doctors combined two existing drugs in new clinical trials. Nearly half of treatment-resistant patients achieved remission after 48 weeks.
Scientists discovered how hidden blood mutations worsen inflammatory bowel disease in millions of Americans. Even better, they found an existing safe drug that reverses the damage.
A groundbreaking treatment for Huntington's disease just cleared a major hurdle, bringing hope to 240,000 Americans affected by this devastating condition. The experimental therapy could become the first disease-modifying treatment for a disorder that has had none.
A groundbreaking treatment for myotonic dystrophy type 1 reduced toxic proteins by 40% and improved muscle function in patients who've never had disease-modifying options. The New England Journal of Medicine just published results that could lead to the first approved therapy for this progressive, often fatal disease.
Researchers discovered how to disguise healthy mitochondria so they can slip into diseased cells undetected, extending the lives of mice with a fatal genetic disorder. The breakthrough could one day help children born with rare mitochondrial diseases.
A new treatment for a rare kidney disease just passed a major test, bringing hope to 330,000 patients in the U.S. and Europe. Vertex's drug successfully reduced a key disease marker by half in late-stage trials.
University of Queensland researchers have developed a breakthrough drug that could transform Motor Neurone Disease from a terminal diagnosis into a manageable chronic condition within five years. The discovery unlocks a previously untargetable immune receptor that plays a key role in neurodegenerative diseases.
Pearl Jam's Eddie Vedder and Canadian director Matt Finlin created a documentary following the race to cure epidermolysis bullosa, a devastating skin disease affecting children worldwide. The Netflix film captures breakthrough research that could unlock treatments for thousands of rare diseases.
For the first time, a gene therapy has shown dramatic results in slowing Huntington's disease, offering hope to 8,000 UK families who've had no treatment options until now. Patients receiving the higher dose experienced 75% less disease progression over three years.
Four leading European research institutes have joined forces to speed up treatments for Alzheimer's, Parkinson's, and other brain diseases affecting millions. The CURE-ND Alliance brings together over 2,500 scientists working to transform how we understand and treat neurodegenerative diseases.
A Nashville family transformed their annual Kentucky Derby party into a powerful fundraiser after their daughter was diagnosed with an incurable nerve disease. Last year alone, they raised $75,000 for research into Charcot-Marie-Tooth disease.
Jeff Carroll learned he carried the gene for deadly Huntington's disease. Instead of giving up, he became a neuroscientist dedicated to finding a cure for the condition killing him.
After initially calling it a failed product, the FDA reversed course to allow accelerated approval of a groundbreaking gene therapy that could slow Huntington's disease. The decision brings hope to 40,000 Americans living with the fatal disorder that currently has no cure.
The FDA has accepted a groundbreaking treatment for Alexander disease for priority review, offering hope to families battling a rare neurological condition that has no approved therapies. If approved by September, zilganersen would become the first medicine ever available for this devastating illness.
Showing 20 of 4844